Non-executive director Guo Huaqing increased his stake in Science Popularization Pharmaceutical Group Limited-B (02171.HK) by 30,000 shares, with each share priced at 16.4 Hong Kong dollars.

According to the Wisdom Financial APP, the latest information from the Hong Kong Stock Exchange shows that on November 10th, non-executive director Guo Huaqing increased his holdings of SciClone Pharmaceuticals-B (02171.HK) by 30,000 shares, with a unit price of 16.4 Hong Kong dollars, for a total amount of 492,000 Hong Kong dollars. After the increase, the latest number of shares held is approximately 218 million shares, with a shareholding ratio of 37.73%.